Qol Holdings Co.,Ltd.JP:3034Income statement

Market cap
¥68.8B
P/E ratio
9.5x
Cure All Holdings operates pharmacies, provides business outsourcing services to pharmaceutical companies, and manufactures drugs to support healthcare across communities.
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Revenue66,20176,783100,966114,363124,957131,502145,516144,783165,411161,832166,199170,036180,052263,972
Revenue growth (%)-
Cost of revenue---101,346109,196114,625125,867126,919144,317140,730143,035146,531156,802224,916
Gross profit---13,01715,76116,87619,64817,86321,09421,10223,16323,50423,24939,056
Gross margin (%)---
Operating margin (%)---
Operating expenses ---8,7739,05110,01010,55710,81213,36113,73713,30814,00914,92525,591
Operating income ---4,2436,7096,8659,0917,0507,7337,3649,8559,4958,32413,465
Income before tax 3,2382,8292,2084,2626,6557,0659,3337,2088,0247,40310,09410,0989,25613,831
Pretax margin (%)4.93.72.23.75.35.46.454.94.66.15.95.15.2
Provision for income taxes---1,7182,7012,7703,3923,1943,4133,3424,1923,9253,9795,363
Effective tax rate (%)---
Net income 1,0762,3119082,1633,6944,4095,0183,9704,2693,5525,4955,6584,8807,476
Net income margin (%)
Earnings per share62.1152.7625.1163.33105.81128.35141.19101.73107.2389.55149.51152.96131.11137.97
Diluted EPS----98.96-130.19-------
Dividend per share--------282828323034
EBITDA---
EBITDA margin (%)---